A lingering mistake
- H1-Antihistamines. Altschuler, Eric L.; Kast, Richard E. // New England Journal of Medicine;3/17/2005, Vol. 352 Issue 11, p1155
A letter to the editor is presented in response to an article by F. Estelle R. Simons about six classes of medicines with H1-antihistamine properties, which appeared in a previous issue.
- CAN ANTIHISTAMINES CAUSE IMPOTENCE. L.S. // Prevention;Jul89, Vol. 41 Issue 7, p129
Presents a letter to the editor, inquiring about the negative effects of antihistamines.
- Medicare: Ready for a perfect storm of reform? // CMAJ: Canadian Medical Association Journal;2/28/2006, Vol. 174 Issue 5, p597
The article discusses possible health care reforms to be implemented in Canada after the establishment of a new Conservative government in the country. The government is described as more open to private enterprise than the previous administration, and is likely to draw consultants and advisers...
- Primary outcome measures. Brown, Simon G. A. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;8/22/2009, Vol. 339 Issue 7718, p416
A letter to the editor is presented in response to the article "Should antihistamines be used to treat anaphylaxis," by D. A. Andreae and M. H. Andreae published in the July 10, 2009 issue.
- Fexofenadine in higher doses in chronic spontaneous urticaria. Godse, Kiran V.; Nadkarni, Nitin J.; Jani, Gaurang; Ghate, Sunil // Indian Dermatology Online Journal;2010, Vol. 1 Issue 1, p45
A letter to the editor is presented in which the use of higher doses of fexofenadine, a nonsedating antihistamine, as a treatment for patients suffering from chronic urticaria is discussed.
- Third-generation antihistamines. Laughton, Jim // Pulse;6/14/2004, Vol. 64 Issue 24, p27
Presents a letter about an article in the May 24, 2004 issue of "Pulse" on third-generation antihistamines.
- Third-generation antihistamines. // Pulse;6/14/2004, Vol. 64 Issue 24, p27
Presents the article author's response to a letter on third-generation antihistamines.
- Buclizine is back again! This time as a pediatric appetite stimulant. Babu, Thirunavukkarasu Arun // Indian Journal of Pharmacology;Apr2011, Vol. 43 Issue 2, p219
A letter to the editor is presented regarding the use of the antihistaminic drug buclizine as pediatric appetite stimulant.
- OLOPATADINE IN CHRONIC IDIOPATHIC URTICARIA. Godse, Kiran V. // Indian Journal of Dermatology;Apr-Jun2009, Vol. 54 Issue 2, p191
A letter to the editor about the use of olopatadine hydrochloride for treating idiopathic urticaria is presented.